Oncotarget
The cover for issue 70 of Oncotarget features Figure 4B, "BRAF/MEK inhibitor-based phase 1 trial therapy according to BRAF or KRAS hotspot mutation status," by Wang, et al.
Drug repurposing using high-throughput screening identifies a promising drug combination to treat adrenocortical carcinoma |
https://doi.org/10.18632/oncotarget.26091 Antonio M. Lerario, and Gary D. Hammer |
33245-33246 |
PDF | How to cite | Order a Reprint |
The role of p16 as a biomarker in nonoropharyngeal head and neck cancer |
https://doi.org/10.18632/oncotarget.26053 Lucas K. Vitzthum, and Loren K. Mell |
33247-33248 |
PDF | How to cite | Order a Reprint |
Modeling and antitumor studies of a modified L–penetratin peptide targeting E2F in lung cancer and prostate cancer |
https://doi.org/10.18632/oncotarget.26064 Tazeem Shaik, Gulam M, Rather, Nitu Bansal, Tamara Minko, Olga Garbuzenko, Zoltan Szekely, Emine E. Abali, Debabrata Banerjee, John E. Kerrigan, Kathleen W. Scotto, and Joseph R. Bertino |
33249-33257 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Outcome analysis of Phase I trial patients with metastatic KRAS and/or TP53 mutant non-small cell lung cancer |
https://doi.org/10.18632/oncotarget.25947 Yudong Wang, Zhijie Wang, Sarina Piha-Paul, Filip Janku, Vivek Subbiah, Naiyi Shi, Kenneth Hess, Russell Broaddus, Baoen Shan, Aung Naing, David Hong, Apostolia M. Tsimberidou, Daniel Karp, Charles Lu, Vali Papadimitrakopoulou, John Heymach, Funda Meric-Bernstam, and Siqing Fu |
33258-33270 |
Abstract | PDF | HTML | How to cite | Press Release | Order a Reprint |
Glioblastoma in the setting of prior lower grade gliomas – insights from SEER database |
https://doi.org/10.18632/oncotarget.26014 Ha Son Nguyen, Benjamin Best, Ninh B. Doan, Michael Gelsomino, Saman Shabani, Ahmed J. Awad, Mayank Kaushal, and Martin M. Mortazavi |
33271-33277 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Metabolite quantification of faecal extracts from colorectal cancer patients and healthy controls |
https://doi.org/10.18632/oncotarget.26022 Gwénaëlle Le Gall, Kiran Guttula, Lee Kellingray, Adrian J. Tett, Rogier ten Hoopen, E. Kate Kemsley, George M. Savva, Ashraf Ibrahim, and Arjan Narbad |
33278-33289 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Single-cell transcriptomes reveal the mechanism for a breast cancer prognostic gene panel |
https://doi.org/10.18632/oncotarget.26044 Shengwen Calvin Li, Andres Stucky, Xuelian Chen, Mustafa H. Kabeer, William G. Loudon, Ashley S. Plant, Lilibeth Torno, Chaitali S. Nangia, Jin Cai, Gang Zhang, and Jiang F. Zhong |
33290-33301 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
The vesicular transfer of CLIC1 from glioblastoma to microvascular endothelial cells requires TRPM7 |
https://doi.org/10.18632/oncotarget.26048 Dominique Thuringer, Gaetan Chanteloup, Pascale Winckler, and Carmen Garrido |
33302-33311 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Role of textural heterogeneity parameters in patient selection for 177Lu-PSMA therapy via response prediction |
https://doi.org/10.18632/oncotarget.26051 Zain Khurshid, Hojjat Ahmadzadehfar, Florian C. Gaertner, László Papp, Norbert Zsóter, Markus Essler, and Ralph A. Bundschuh |
33312-33321 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (Macaca fascicularis) |
https://doi.org/10.18632/oncotarget.26055 Takao Ukaji, Ai Takemoto, Ryohei Katayama, Kengo Takeuchi, and Naoya Fujita |
33322-33336 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer |
https://doi.org/10.18632/oncotarget.26071 Chie Kikutake, Minako Yoshihara, Tetsuya Sato, Daisuke Saito, and Mikita Suyama |
33337-33347 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling |
https://doi.org/10.18632/oncotarget.26072 Khalid N. Al-Zahrani, David P. Cook, Barbara C. Vanderhyden, and Luc A. Sabourin |
33348-33359 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Loss of Gadd45b accelerates BCR-ABL-driven CML |
https://doi.org/10.18632/oncotarget.26076 Xiaojin Sha, Barbara Hoffman, and Dan A. Liebermann |
33360-33367 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells |
https://doi.org/10.18632/oncotarget.26077 Arturo Contis-Montes de Oca, Estefanía Rodarte-Valle, Martha Cecilia Rosales-Hernández, Edgar Abarca-Rojano, Saúl Rojas-Hernández, Manuel Jonathan Fragoso-Vázquez, Jessica Elena Mendieta-Wejebe, Ana María Correa-Basurto, Ismael Vázquez-Moctezuma, and José Correa-Basurto |
33368-33381 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Genetic disruption of calpain-1 and calpain-2 attenuates tumorigenesis in mouse models of HER2+ breast cancer and sensitizes cancer cells to doxorubicin and lapatinib |
https://doi.org/10.18632/oncotarget.26078 James A. MacLeod, Yan Gao, Christine Hall, William J. Muller, Taranjit S. Gujral, and Peter A. Greer |
33382-33395 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Meta-analysis of the likelihood of FOXC2 expression in early- and late-stage tumors |
https://doi.org/10.18632/oncotarget.26087 Tsutomu Kume, and Tarek Shackour |
33396-33402 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Cancer stem cells in progression of colorectal cancer |
https://doi.org/10.18632/oncotarget.23607 Yujuan Zhou, Longzheng Xia, Heran Wang, Linda Oyang, Min Su, Qiang Liu, Jingguan Lin, Shiming Tan, Yutong Tian, Qianjin Liao, and Deliang Cao |
33403-33415 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy |
https://doi.org/10.18632/oncotarget.26058 Jack W. Singer, Angela Fleischman, Suliman Al-Fayoumi, John O. Mascarenhas, Qiang Yu, and Anupriya Agarwal |
33416-33439 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Correction: Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer |
https://doi.org/10.18632/oncotarget.26113 Karina Brüstle, and Bettina Heidecker |
33440-33440 |
Correction | PDF | How to cite |
Correction: Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel |
https://doi.org/10.18632/oncotarget.26114 J. Tyson McDonald, Athena Kritharis, Afshin Beheshti, Monika Pilichowska, Kristine Burgess, Luisel Ricks-Santi, Elizabeth McNiel, Cheryl A. London, Dashnamoorthy Ravi, and Andrew M. Evens |
33441-33441 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC